|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Right Living Donor Liver Transplantation: An Option for Adult Patients: Single Institution Experience With 74 Patients显示文摘 | Massimo Malagó Giuliano Testa Andrea Frilling Silvio Nadalin Camino Valentin-Gamazo Andreas Paul Hauke Lang Ulrich Treichel Vito Cicinnati Guido Gerken Christoph Erich Broelsch | 2003 | Annals of Surgery2003，，6： | 2 |
| 2 | Laboratory Diagnosis and Nonoperative Management of Biliary Complications in Living Donor Liver Transplant Patients显示文摘 | Mukund Venu Russell D. Brown Rita Lepe Jamie Berkes Scott J. Cotler Enrico Benedetti Giuliano Testa Rama P. Venu | 2007 | Journal of Clinical Gastroenterology2007，，5： | 2 |
| 3 | Complications of Biliary Tract in Liver Transplantation显示文摘 | Giuliano Testa Massimo Malagò Christoph E. Broelsch | 2001 | World Journal of Surgery2001，，10： | 2 |
| 4 | Multidetector computed tomographic cholangiography in the evaluation of potential living liver donors显示文摘 | Tobias Schroeder Massimo Malago J?rg F. Debatin Giuliano Testa Silvio Nadalin Christoph E. Broelsch Stefan G. Ruehm | 2002 | Transplantation2002，，12： | 1 |
| 5 | Reactive Lymphoid Hyperplasia of the Liver: A Clinicopathological Study of 7 Cases显示文摘 | Lei Yuan Youlei Zhang Yi Wang Wenming Cong Mengchao Wu Giuliano Testa | 2012 | HPB Surgery2012，，： | 1 |
| 6 | Colon carcinoma in patients undergoing liver transplantation显示文摘 | Renata Fabia Marlon F Levy Giuliano Testa Samuel Obiekwe Robert M Goldstein Bo S Husberg Thomas A Gonwa Goran B Klintmalm | 1998 | The American Journal of Surgery1998，，3： | 1 |
| 7 | High molecular weight polyethylene glycol (PEG 15-20) maintains mucosal microbial barrier function during intestinal graft preservation显示文摘 | Vesta Valuckaite John Seal Olga Zaborina Maria Tretiakova Giuliano Testa John C. Alverdy | 2013 | Journal of Surgical Research2013，，2： | 1 |
| 8 | Serum bile acids in liver transplantation – early indicator for acute rejection and monitor for antirejection therapy显示文摘 | H. Jan?en Reinhard Lange Jochen Erhard Giuliano Testa Massimo Malagó Petra Jan?en Friedrich W. Eigler Christoph E. Broelsch | 2001 | Transplant International2001，，6： | 1 |
| 9 | Serum bile acids in liver transplantation – early indicator for acute rejection and monitor for antirejection therapy显示文摘 | H. Jan?en Reinhard Lange Jochen Erhard Giuliano Testa Massimo Malagó Petra Jan?en Friedrich W. Eigler Christoph E. Broelsch | 2001 | Transplant International2001，，6： | 1 |
| 10 | Sirolimus and Cardiovascular Disease Risk in Liver Transplantation显示文摘 | Greg J. McKenna James F. Trotter Erik Klintmalm Richard Ruiz Nicholas Onaca Giuliano Testa Giovanna Saracino Marlon F. Levy Robert M. Goldstein Goran B. Klintmalm | 2013 | Transplantation Journal2013，，1： | 1 |
| 11 | A narrative review of the current and future role of robotic surgery in liver surgery and transplantation显示文摘Background:Minimally invasive surgery(MIS)is the technique of choice in selected patients for the treatment of liver tumors.The robotic approach is considered today the natural evolution of MIS.The application of the robotic technique in liver transplantation(LT)has been recently evaluated,especially in the living donation.The aim of this paper is to review the current role of the MIS and robotic donor hepatectomy in the literature and to evaluate the possible future implication in the transplant field.Methods:We conducted a narrative review using PubMed and Google Scholar for reports published so far,using the following keywords:minimally invasive liver surgery,laparoscopic liver surgery,robotic liver surgery,robotic living donation,laparoscopic donor hepatectomy and robotic donor hepatectomy.Results:Several advantages have been claimed in favor of robotic surgery:three-dimensional(3-D)imaging with stable and high-definition view;a more rapid learning curve than the laparoscopic one;the lack of hand tremors and the freedom of movements.Compared to open surgery,the benefits showed in the studies evaluating the robotic approach in the living donation are:less postoperative pain,the shorter period before returning to normal activity despite sustaining longer operation time.Furthermore,the 3-D and magnification view makes the technique excellent in distinguishing the right plane of transection,vascular and biliary anatomy,associated with high precision of the movements and a better bleeding control(essential for donor safety)and lower rate of vascular injury.Conclusions:The current literature does not fully support the superiority of the robotic approach versus laparoscopic or open method in living donor hepatectomy.Robotic donor hepatectomy performed by teams with high expertise and in properly selected living donors is safe and feasible.However,further data are necessary to evaluate properly the role of robotic surgery in the field of living donation. | Michele Finotti Francesco D’Amico David Mulligan Giuliano Testa | 2023 | Hepatobiliary Surgery and Nutrition2023，12，1： | 1 |
| 12 | Complications of Biliary Tract in Liver Transplantation显示文摘 | Giuliano Testa Massimo Malagò Christoph E. Broelsch | 2001 | World Journal of Surgery2001，，10： | 1 |
| 13 | 活体亲属阶段性肠移植:由实验阶段过渡到标准的手术显示文摘活体肠移植不久前问世,是尸体肠移植的重要替代手术。本文总结了单中心经验。材料和方法:自1998年4月至2004年10月,对11例患者(7例男性,4例女性;平均年龄26岁)进行了12次活体肠移植。其中4例为年龄不足5岁的儿童。儿童受者和成人受者均接受了远段回肠移植,长度分别为150—180cm和200cm。免疫抑制方案包括胸腺球蛋白诱导和他克莫司加(或不加)霉酚酸酯和类固醇激素维持治疗。结果:所有的供者均恢复良好,末发生任何早期或晚期并发症。患者1年和3年总体生存率为82%,移植物生存率为75%。于2000年1月以后接受移植的后8例患者,患者和移植物1年生存率分别为100%和88%。中位住院时间为36天(范围13~290天)。移植后第一年中,只有接受完全不匹配移植物的患者发生了一次急性排斥反应(8%)。所有存活的患者目前均接受肠道营养而无需额外输液。结论:活体肠移植是治疗不可逆性肠衰竭中的一项重要策略。由于医疗团队经验的积累,数年中移植结果有所改善。 | Benedetti , Enrico Holterman, Mark Asolati, Massimo Di Domenico, Stefano Oberholzer, Jose Sankary, Howard Abcarian, Herand Testa,Giuliano | 2007 | 医学信息(手术学分册)2007，20，8： | 0 |
| 14 | Adult to adult living related liver transplantation: Where do we currently stand?显示文摘Adult to adult living donor liver transplantation (AALDLT) was first preformed in the United States in 1997. The procedure was rapidly integrated into clinical practice, but in 2002, possibly due to the first widely publicized donor death, the number of living liver donors plummeted. The number of donors has since reached a steady plateau far below its initial peak. In this review we evaluate the current climate of AALDLT. Specifically, we focus on several issues key to the success of AALDLT: determining the optimal indications for AALDLT, balancing graft size and donor safety, assuring adequate outflow, minimizing biliary complications, and maintaining ethical practices. We conclude by offering suggestions for the future of AALDLT in United States transplantation centers. | Erica M Carlisle Giuliano Testa | 2012 | World Journal of Gastroenterology2012，18，46： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员